The Federal Trade Commission, along with California and Utah, has sued telehealth company Hims & Hers for allegedly charging patients for prescription subscriptions without their consent and sharing sensitive health data with tech giants like Meta and Snap. The complaint claims the company misled consumers with "free" consultations, enrolled them in recurring subscriptions without clear consent, and made cancellations difficult. Hims & Hers denies the allegations, but its stock dropped over 11% following the lawsuit. This case could impact how telehealth companies handle billing, privacy, and advertising in the future.
The Federal Trade Commission (FTC) is suing healthcare company Hims & Hers for allegedly sharing customers' sensitive medical data with advertisers and tech giants like Meta and Snap without consent. The FTC claims Hims & Hers used pixel trackers to ...
Wall Street experienced a significant selloff with the Nasdaq 100 nearing correction territory and the Dow Jones dropping over 1,000 points, wiping out recent gains. The selloff is driven by fears of rising interest rates after three Federal Reserve ...
The Federal Trade Commission (FTC) has filed a lawsuit against Hims & Hers Health, Inc., alleging the company misled consumers by charging for prescriptions immediately after intake forms were submitted, despite promising consultations to find suitab...
The U.S. Federal Trade Commission (FTC) has sued telehealth company Hims & Hers for allegedly sharing users' sensitive health data with advertisers like Meta and Snap, despite promising privacy. The FTC also accused the company of deceptive billing, ...
The Federal Trade Commission sued telehealth company Hims & Hers, accusing it of improperly sharing sensitive user health data with advertisers like Meta and Snap without consent. The FTC also alleges the company charged customers for prescriptions b...
